BeStock  

Takeda Pharmaceutical TAK

US equityMarket cap rank #310Infectious Disease
$21.77 +$0.36 (+1.68%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $22.09 +1.47%
Open$21.82
Prev close$21.41
Day range$21.74 – $22.07
Volume3.80M
Market cap$69.76B
P/E (TTM)311.0
Dividend yield1.44%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership51.3%-1.15 pts vs. prior quarter
Institutions holding728-2 vs. prior quarter
Insider trades (recent)19 buys / 31 sellsNet selling
Short interest0.10% of floatDays to cover 1.0 · as of 30 Oct 2026
Short-sale volume share24.9%5-day average of daily volume

Short-sale volume as % of daily volume

9%18%27%36%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$1.16M (14 inflow days, 6 outflow days).

Net flow by order size, last 20 sessions

−$5.4MSuper+$6.6MBig−$1.8MMid+$2.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 23.6% of shares outstanding.

Largest holders

  • BlackRock9.21%
  • Nomura Asset Management4.40%
  • Vanguard Capital Management, LLC3.93%
  • Sumitomo Mitsui Trust Asset Management3.11%
  • Capital Research3.00%
  • Amova Asset Management2.14%
  • Daiwa Asset Management2.00%
  • Nissay Asset Management Corporation1.55%

By investor type

  • Mutual Fund45.36%
  • Public Company1.76%
  • Sovereign Wealth Fund1.29%
  • Private Company1.28%
  • Hedge Fund0.85%
  • Government Pension Fund0.53%
  • Insurance Company0.20%
  • Individual/Insider0.12%

Reported short interest has held roughly steady near 0.10% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Global X Japan Co. Ltd. Mutual Fund 2026/Q3 +1,319,474 0.1%
Capital Research Mutual Fund 2026/Q3 +2,380,130 3.0%
Amundi Asset Management Mutual Fund 2026/Q3 +875,922 0.4%
BlackRock Mutual Fund 2026/Q3 +20,502,452 9.1%
Charles Schwab Investment Management Mutual Fund 2026/Q3 +848,164 0.5%
Barclays PLC Public Company 2026/Q3 +35,063,130 0.0%
Capital Research Mutual Fund 2026/Q3 +6,318,200 3.1%
Strategic Advisers LLC Mutual Fund 2026/Q3 +4,202,114 0.8%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +3,377,462 0.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +2,385,044 3.9%
Nomura Asset Management Mutual Fund 2026/Q3 +1,276,800 4.5%
Morgan Stanley Public Company 2026/Q3 +1,239,470 0.3%
Vanguard Asset Management, Limited Mutual Fund 2026/Q3 +890,118 0.4%
BlackRock Mutual Fund 2026/Q3 +20,379,712 9.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +774,000 3.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Nov 2026 Giles Platford President of International Business Unit Open Market Disposition -55,617 $20.90 170,713
1 Nov 2026 Teresa Marie Bitetti President of the Global Oncology Business Unit Private Disposition -46,609 $0.13 124,869
31 Oct 2026 Giles Platford President of International Business Unit Intent to Sell (Form 144) -55,617 $20.17 –
13 Sep 2026 Lauren Duprey Chief Transformation Officer Open Market Disposition -34,535 $18.54 100,278
1 Sep 2026 Andrew S. Plump President of Research & Development and Representative Director Automatic Disposition -116,191 $18.49 651,690
18 Aug 2026 Andrew S. Plump President of Research & Development and Representative Director Automatic Disposition -19,651 $18.49 767,881
17 Aug 2026 Nicola Greenway Open Market Disposition -12,980 $18.11 –
13 Aug 2026 Nicola Greenway Intent to Sell (Form 144) -12,980 $17.39 –
10 Aug 2026 Elaine Shannon President of Global Supply & Quality Open Market Disposition -20,363 $17.55 19,237
9 Aug 2026 Andrew S. Plump President of Research & Development and Representative Director Private Disposition -165,393 $17.10 787,532
9 Aug 2026 Giles Platford President of International Business Unit Private Disposition -31,083 $17.10 216,298
9 Aug 2026 Farajallah Awny Botros Chief Medical Officer Private Disposition -14,006 $17.10 61,965
9 Aug 2026 Julie Kim Chief Executive Officer Private Disposition -89,090 $17.10 260,209
9 Aug 2026 Teresa Marie Bitetti President of the Global Oncology Business Unit Private Disposition -50,012 $17.10 162,378
9 Aug 2026 Ramy Ibrahim Private Disposition -7,277 $17.10 52,604
9 Aug 2026 Lauren Duprey Chief Transformation Officer Private Disposition -47,586 $17.10 134,813
9 Aug 2026 Gabriele Ricci Chief Data & Technology Officer Private Disposition -25,088 $17.10 110,216
9 Aug 2026 Marcello Pignagnoli Agosti Interim Head of Strategy & Portfolio Development Private Disposition -22,957 $17.10 120,051
9 Aug 2026 Elaine Shannon President of Global Supply & Quality Private Disposition -3,978 $17.10 19,237
9 Aug 2026 Natalie Furney Global General Counsel Private Disposition -30,868 $17.10 32,890

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,066,552 0.1% 1.0
15 Oct 2026 3,289,262 0.1% 1.1
30 Sep 2026 2,918,812 0.1% 1.2
15 Sep 2026 4,204,915 0.1% 2.0
31 Aug 2026 4,088,761 0.1% 1.8
14 Aug 2026 2,992,883 0.1% 1.0

Discussion

No comments yet — be the first to weigh in on TAK.

Sign in to join the discussion.

Scroll to Top